ADVANCING RESEARCH CAPACITY IN WEST AFRICA (ARC-WA PROJECT)

A CEPI-supported study co-led by IVI and MRCG to strengthen clinical trial and epidemic preparedness across West Africa. It focuses on enhancing Good Clinical Practice (GCP)-compliant trial capacity, particularly for Lassa fever vaccines in Nigeria, Liberia, and Sierra Leone. The project also builds emergency response systems by assessing infrastructure, training stakeholders, and creating a sustainable framework for outbreak-ready research across the region.